Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer: Challenges and Opportunities

JACC CardioOncol. 2022 Sep 20;4(3):351-353. doi: 10.1016/j.jaccao.2022.08.005. eCollection 2022 Sep.

Authors

Deborah M Siegal^{1

2}, Darryl P Leong^{3

4}

Affiliations

¹ Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
² Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
³ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁴ Population Health Research Institute, Hamilton, Ontario, Canada.

No abstract available

Keywords: DOAC; anticoagulation; atrial fibrillation; cancer; cardio-oncology; vitamin K antagonist.

Publication types

Editorial